Phentermine/Gastric Band Weight Loss Study

• Status: Withdrawn
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, randomized, double-blind controlled trial. The goal is to show whether the administration of daily oral Phentermine will augment patient weight loss and resolve obesity associated comorbidities following gastric band operation.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Atrium Health; Carolinas Healthcare System
• Treatments: Phentermine

Criteria

Inclusion Criteria:

• Adult age 18-65

• BMI 35-55

• Approved for gastric band operation

Exclusion Criteria:

• A known allergy to Phentermine

• Take medications for Attention Deficit Disorder (ADD)

• Monoamine oxidase inhibitors (MAOI)for depression

• Selective serotonin reuptake inhibitor (SSRIs)for depression

• History of heart problems (congested heart failure, coronary artery disease,cardiac stents, cardiac arrhythmias

• Hyperthyroidism

• Glaucoma

• Psychosis

• History of drug abuse

• Uncontrolled hypertension (diastolic >85)